These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33612035)

  • 1. Aripiprazole for the treatment of Tourette syndrome.
    Cox JH; Cavanna AE
    Expert Rev Neurother; 2021 Apr; 21(4):381-391. PubMed ID: 33612035
    [No Abstract]   [Full Text] [Related]  

  • 2. The Effectiveness of Aripiprazole for Tics, Social Adjustment, and Parental Stress in Children and Adolescents with Tourette's Disorder.
    Wang LJ; Chou WJ; Chou MC; Gau SS
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):442-8. PubMed ID: 27028456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders.
    Cox JH; Seri S; Cavanna AE
    Pediatric Health Med Ther; 2016; 7():57-64. PubMed ID: 29388585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.
    Lyon GJ; Samar S; Jummani R; Hirsch S; Spirgel A; Goldman R; Coffey BJ
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):623-33. PubMed ID: 20035580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and emerging pharmacotherapeutic strategies for Tourette syndrome.
    Cavanna AE
    Expert Opin Pharmacother; 2022 Sep; 23(13):1523-1533. PubMed ID: 35913140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for tics in adult patients with Tourette syndrome and other tic disorders.
    Badenoch J; Cavanna AE
    Neurol Sci; 2020 Jul; 41(7):1923-1926. PubMed ID: 32170503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis.
    Hollis C; Pennant M; Cuenca J; Glazebrook C; Kendall T; Whittington C; Stockton S; Larsson L; Bunton P; Dobson S; Groom M; Hedderly T; Heyman I; Jackson GM; Jackson S; Murphy T; Rickards H; Robertson M; Stern J
    Health Technol Assess; 2016 Jan; 20(4):1-450, vii-viii. PubMed ID: 26786936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review.
    Besag FM; Vasey MJ; Lao KS; Chowdhury U; Stern JS
    J Psychopharmacol; 2021 Sep; 35(9):1037-1061. PubMed ID: 34286606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
    Cui YH; Zheng Y; Yang YP; Liu J; Li J
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life events and Tourette syndrome.
    Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
    Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole in treatment of Gilles de la Tourette syndrome - New therapeutic option.
    Janik P; Szejko N
    Neurol Neurochir Pol; 2018; 52(1):84-87. PubMed ID: 29154107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder.
    Seo WS; Sung HM; Sea HS; Bai DS
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):197-205. PubMed ID: 18439116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
    Rizzo R; Gulisano M; Calì PV; Curatolo P
    Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms.
    Lenka A; Jankovic J
    Expert Rev Neurother; 2024 Jul; ():1-9. PubMed ID: 39034647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors.
    Groth C
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of tic disorders and Tourette Syndrome.
    Roessner V; Schoenefeld K; Buse J; Bender S; Ehrlich S; Münchau A
    Neuropharmacology; 2013 May; 68():143-9. PubMed ID: 22728760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.
    Budman CL
    Drugs; 2014 Jul; 74(11):1177-93. PubMed ID: 25034359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
    Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms compatible with long COVID in an Italian pediatric cohort of Tourette patients with and without SARS‑CoV‑2 infection: a short-term follow-up assessment.
    Prato A; Salerno AM; Saia F; Maugeri N; Zanini A; Scerbo M; Barone R; Rizzo R
    BMC Pediatr; 2023 May; 23(1):222. PubMed ID: 37147589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study.
    Müller-Vahl KR; Pisarenko A; Szejko N; Haas M; Fremer C; Jakubovski E; Musil R; Münchau A; Neuner I; Huys D; van Elst LT; Schröder C; Ringlstetter R; Koch A; Jenz EB; Großhennig A
    Psychiatry Res; 2023 May; 323():115135. PubMed ID: 36878177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.